Apyx Historical Cash Flow

APYX Stock  USD 1.61  0.08  4.73%   
Analysis of Apyx Medical cash flow over time is an excellent tool to project Apyx Medical future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Change In Cash of 35.1 M or Change In Working Capital of 5.8 M as it is a great indicator of Apyx Medical ability to facilitate future growth, repay debt on time or pay out dividends.
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining Apyx Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Apyx Medical is a good buy for the upcoming year.
  
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

About Apyx Cash Flow Analysis

The Cash Flow Statement is a financial statement that shows how changes in Apyx balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Apyx's non-liquid assets can be easily converted into cash.

Apyx Medical Cash Flow Chart

At this time, Apyx Medical's Change Receivables is fairly stable compared to the past year. Change To Netincome is likely to rise to about 6.7 M in 2024, whereas Free Cash Flow is likely to drop (6.1 M) in 2024.

Begin Period Cash Flow

The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.

Stock Based Compensation

Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.
Most accounts from Apyx Medical's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Apyx Medical current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.At this time, Apyx Medical's Change Receivables is fairly stable compared to the past year. Change To Netincome is likely to rise to about 6.7 M in 2024, whereas Free Cash Flow is likely to drop (6.1 M) in 2024.

Apyx Medical cash flow statement Correlations

0.350.570.37-0.34-0.180.09-0.420.060.060.08-0.070.36-0.370.280.12-0.11-0.060.06-0.04-0.29
0.350.020.36-0.43-0.21-0.010.32-0.090.62-0.060.030.230.140.020.060.410.03-0.01-0.040.4
0.570.020.71-0.6-0.170.48-0.43-0.18-0.50.410.370.19-0.630.15-0.06-0.1-0.420.40.5-0.49
0.370.360.71-0.42-0.050.780.1-0.70.00.160.680.34-0.040.190.32-0.16-0.70.760.720.06
-0.34-0.43-0.6-0.420.390.070.24-0.240.44-0.390.14-0.290.62-0.260.22-0.35-0.150.140.030.48
-0.18-0.21-0.17-0.050.390.160.32-0.230.130.280.17-0.160.24-0.140.5-0.13-0.160.180.140.1
0.09-0.010.480.780.070.160.29-0.930.060.120.930.060.10.00.4-0.16-0.990.990.930.25
-0.420.32-0.430.10.240.320.29-0.50.52-0.320.35-0.080.55-0.130.360.22-0.290.350.250.62
0.06-0.09-0.18-0.7-0.24-0.23-0.93-0.5-0.310.07-0.88-0.09-0.41-0.01-0.520.20.92-0.96-0.83-0.49
0.060.62-0.50.00.440.130.060.52-0.31-0.40.15-0.020.69-0.20.250.09-0.10.12-0.020.81
0.08-0.060.410.16-0.390.280.12-0.320.07-0.40.13-0.11-0.52-0.1-0.050.22-0.150.030.23-0.47
-0.070.030.370.680.140.170.930.35-0.880.150.13-0.280.1-0.360.370.06-0.910.920.980.35
0.360.230.190.34-0.29-0.160.06-0.08-0.09-0.02-0.11-0.280.220.95-0.01-0.58-0.040.07-0.25-0.14
-0.370.14-0.63-0.040.620.240.10.55-0.410.69-0.520.10.220.130.26-0.44-0.120.2-0.040.7
0.280.020.150.19-0.26-0.140.0-0.13-0.01-0.2-0.1-0.360.950.13-0.07-0.590.020.01-0.32-0.24
0.120.06-0.060.320.220.50.40.36-0.520.25-0.050.37-0.010.26-0.07-0.1-0.360.440.310.32
-0.110.41-0.1-0.16-0.35-0.13-0.160.220.20.090.220.06-0.58-0.44-0.59-0.10.16-0.210.040.09
-0.060.03-0.42-0.7-0.15-0.16-0.99-0.290.92-0.1-0.15-0.91-0.04-0.120.02-0.360.16-0.98-0.91-0.28
0.06-0.010.40.760.140.180.990.35-0.960.120.030.920.070.20.010.44-0.21-0.980.90.31
-0.04-0.040.50.720.030.140.930.25-0.83-0.020.230.98-0.25-0.04-0.320.310.04-0.910.90.2
-0.290.4-0.490.060.480.10.250.62-0.490.81-0.470.35-0.140.7-0.240.320.09-0.280.310.2
Click cells to compare fundamentals

Apyx Medical Account Relationship Matchups

Apyx Medical cash flow statement Accounts

201920202021202220232024 (projected)
Change To Inventory(2.4M)615K(2.9M)(5.6M)1.5M1.5M
Change In Cash42.2M(16.9M)(11.0M)(20.7M)33.5M35.1M
Free Cash Flow(19.8M)(16.6M)(11.2M)(21.3M)(5.8M)(6.1M)
Change In Working Capital(3.3M)(10.3M)(1.8M)(5.2M)5.5M5.8M
Begin Period Cash Flow16.6M58.8M41.9M30.9M10.2M9.1M
Other Cashflows From Financing Activities147K148K262K365K(5.6M)(5.3M)
Depreciation754K887K903K890K692K726.5K
Other Non Cash Items215K996K603K628K2.3M2.4M
Capital Expenditures1.3M581K723K1.0M533K910.0K
Total Cash From Operating Activities(18.5M)(16.1M)(10.4M)(20.3M)(5.2M)(5.0M)
Net Income(19.7M)(11.9M)(15.2M)(23.3M)(18.9M)(17.9M)
Total Cash From Financing Activities147K(73K)24K217K32.2M33.8M
End Period Cash Flow58.8M41.9M30.9M10.2M43.7M45.8M
Change To Liabilities3.4M(965K)4.6M(1.1M)(1.0M)(975.6K)
Change To Account Receivables(4.0M)(558K)(4.9M)1.9M4.0M4.2M
Stock Based Compensation3.6M4.2M5.1M6.7M5.1M5.4M
Total Cashflows From Investing Activities60.5M(581K)(723K)(1.0M)(1.2M)(1.1M)
Change Receivables(4.0M)(558K)(4.9M)1.9M1.7M1.8M
Net Borrowings(60K)(369K)(238K)(148K)(170.2K)(178.7K)
Cash And Cash Equivalents Changes42.2M(16.7M)(11.1M)(21.1M)(19.0M)(18.0M)
Cash Flows Other Operating(274K)(6.7M)1.5M(188K)(216.2K)(205.4K)
Change To Netincome3.7M5.2M5.6M7.1M6.4M6.7M
Change To Operating Activities2.0M(2.1M)4.8M(1.7M)(1.6M)(1.6M)
Investments61.8M(581K)(723K)(1.0M)6.7M7.0M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.